Investigating early signs of age-related macular degeneration in monkeys
Soft drusen in rhesus macaques as a nonhuman primate model of early age-related macular degeneration
This study is looking at how early signs of age-related macular degeneration (AMD) develop in older monkeys to help us understand the condition better and find ways to treat it earlier in people.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11005704 on NIH RePORTER |
What this research studies
This research focuses on understanding the early stages of age-related macular degeneration (AMD) by studying soft drusen in rhesus macaques, which are nonhuman primates that develop similar eye conditions as humans. The researchers will use advanced imaging techniques to monitor the progression of drusen over two years, aiming to uncover the underlying mechanisms of AMD. By utilizing a unique colony of geriatric macaques, the study seeks to provide insights that could lead to earlier interventions for AMD in humans. This approach is significant as it leverages the natural development of AMD-like features in these animals, which can help bridge the gap in current treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research are elderly individuals at risk for or experiencing early signs of age-related macular degeneration.
Not a fit: Patients with advanced age-related macular degeneration or those who do not have risk factors for the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and treatment strategies for age-related macular degeneration, potentially preserving vision in elderly patients.
How similar studies have performed: Previous studies using nonhuman primate models have shown promise in understanding age-related diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Yiu, Glenn — University of California at Davis
- Study coordinator: Yiu, Glenn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.